Juan Wang

发表

Molecular inhibitory mechanism study on the potent inhibitor brigatinib against four crizotinib‐resistant ALK mutations

H. Zhai, X. Y. Zhang, Jing Tu, 2018, Journal of cellular biochemistry.

Investigations of FAK inhibitors: a combination of 3D-QSAR, docking, and molecular dynamics simulations studies

H. Zhai, J. Li, Xiaoyun Zhang, 2018, Journal of biomolecular structure & dynamics.

Tetrazolyl Porphyrin-Based Hydrogen-Bonded Organic Frameworks: Active Sites-Mediated Host-Guest Synergy for Advanced Antimicrobial Applications.

Xiao‐Yu Zhang, Juan Wang, Shuting Fang, 2022, ACS applied materials & interfaces.

Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors

Yuanqiang Wang, M. Shu, Zhi-Hua Lin, 2022, Molecular Diversity.

Enantioselective Cobalt-Catalyzed Reductive Cross-Coupling for the Synthesis of Axially Chiral PhosphineOlefin Ligands

Shangdong Yang, Juan Wang, X. Zhang, 2021, ACS Catalysis.

Three organotin(IV) Schiff-base carboxylates: synthesis, structural characterization and in vitro cytotoxicity against cis-platin-resistent cancer cells

Juan Wang, Shuxian Yu, Chuan Li, 2022, Journal of Molecular Structure.

Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE‐225 and LEQ‐506

H. Zhai, J. Li, X. Y. Zhang, 2017, Pharmacological research.

Design of novel quinoline-aminopiperidine derivatives as Mycobacterium tuberculosis (MTB) GyrB inhibitors: an in silico study

H. Zhai, Xiaoyun Zhang, Wenjuan Lv, 2018, Journal of biomolecular structure & dynamics.

Selective mechanisms and molecular design of 2,4 Diarylaminopyrimidines as ALK inhibitors.

H. Zhai, X. Y. Zhang, Jing Tu, 2018, International journal of biological macromolecules.